Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Valéria Goes Ferreira Pinheiro is active.

Publication


Featured researches published by Valéria Goes Ferreira Pinheiro.


Jornal Brasileiro De Pneumologia | 2009

III Diretrizes para Tuberculose da Sociedade Brasileira de Pneumologia e Tisiologia

Marcus Barreto Conde; Fernando Augusto Fiuza de Melo; Ana Maria Campos Marques; Ninarosa Calzavara Cardoso; Valéria Goes Ferreira Pinheiro; Paulo de Tarso Roth Dalcin; Almério Machado Junior; Antônio Carlos Moreira Lemos; Antonio Ruffino Netto; Betina Durovni; Clemax Couto Sant'Anna; Dinalva Soares Lima; Domenico Capone; Draurio Barreira; Eliana Dias Matos; Fernanda Carvalho de Queiroz Mello; Fernando Cezar David; Giovanni Antonio Marsico; Jorge Barros Afiune; José Roberto Lapa e Silva; Leda Fátima Jamal; Maria Alice da Silva Telles; Mario H. Hirata; Margareth Pretti Dalcolmo; Marcelo Fouad Rabahi; Michelle Cailleaux-Cesar; Moises Palaci; Nelson Morrone; Renata Leborato Guerra; Reynaldo Dietze

New scientific articles about tuberculosis (TB) are published daily worldwide. However, it is difficult for health care workers, overloaded with work, to stay abreast of the latest research findings and to discern which information can and should be used in their daily practice on assisting TB patients. The purpose of the III Brazilian Thoracic Association (BTA) Guidelines on TB is to critically review the most recent national and international scientific information on TB, presenting an updated text with the most current and useful tools against TB to health care workers in our country. The III BTA Guidelines on TB have been developed by the BTA Committee on TB and the TB Work Group, based on the text of the II BTA Guidelines on TB (2004). We reviewed the following databases: LILACS (SciELO) and PubMed (Medline). The level of evidence of the cited articles was determined, and 24 recommendations on TB have been evaluated, discussed by all of the members of the BTA Committee on TB and of the TB Work Group, and highlighted. The first version of the present Guidelines was posted on the BTA website and was available for public consultation for three weeks. Comments and critiques were evaluated. The level of scientific evidence of each reference was evaluated before its acceptance for use in the final text.


Brazilian Journal of Infectious Diseases | 2006

Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis

Valéria Goes Ferreira Pinheiro; Lysiane M.A Ramos; Helena Serra Azul Monteiro; Elizabeth Clara Barroso; Oluma Y. Bushen; Mônica Cardoso Façanha; Charles A. Peloquin; Richard L. Guerrant; Aldo A. M. Lima

Low antimycobacterial drug concentrations have been observed in tuberculosis (TB) patients under treatment. The lactulose/mannitol urinary excretion test (L/M), normally used to measure intestinal permeability, may be useful to assess drug absorption. The objective of this research was to study intestinal absorptive function and bioavailability of rifampin and isoniazid in TB patients. A cross sectional study was done with 41 patients and 28 healthy controls, using the L/M test. The bioavailabilities of rifampin (R) and isoniazid (H) were evaluated in 18 patients receiving full doses. Urinary excretion of mannitol and lactulose, measured by HPLC, was significantly lower in TB patients. The serum concentrations of the drugs were below the expected range for R (8-24 mcg/mL) or H (3-6 mcg/mL) in 16/18 patients. Analyzing the drugs individually, 12/18 patients had low serum concentrations of R, 13/18 for H and 8/18 for both drugs. We suggest that there is a decrease in the functional absorptive area of the intestine in TB patients, which would explain the reduced serum concentrations of antituberculosis drugs. There is a need for new approaches to improve drug bioavailability in TB patients.


Jornal De Pneumologia | 2001

Prevalência da tuberculose multirresistente no Estado do Ceará, 1990-1999

Elizabeth Clara Barroso; Jorge Luis Nobre Rodrigues; Valéria Goes Ferreira Pinheiro; Creuza L. Campelo

Multidrug-resistant tuberculosis (MDR-TB) is a worldwide concern but its magnitude in the state of Ceara - Northeastern Brazil has been so far unknown. Objectives: To determine the prevalence of MDR-TB among us as well as the sesceptibility of Mycobacterium tuberculosis> to antituberculosis drugs. Methods: A retrospective study was conducted using 1,500 susceptibility tests (ST) for rifampin (RFM), isoniazid (INH), streptomycin (SM), pyrazinamide (PYZ), ethambutol (ETM) and ethionamide (ETH) that were performed at the Central Laboratory of the State of Ceara (LACEN) between 1990 and 1999. The proportion method test was used. Results: Of the 1,500 stains studied, 404 (27%) were resistant to at least one drug, including both primary and acquired resistance. MDR-TB, defined as resistance to at least rifampin and isoniazid was observed in 266 (17.7%) patients. During the study period, there were 41,073 TB cases and MDR-TB prevalence was 0.65% in our state. Among the patients studied, 62.3% were men and mean age was 40.17 ± 14.62. Overall prevalence for single-drug resistance was 8.1% (INH = 5.7%; SM = 1.5%; and RFP = 0.9%). Resistance to 2, 3, 4, 5 and 6 drugs was, respectively, 10.8%; 3.1%; 0.9%; 1.5%; and 2.9%. HIV testing was performed in all inpatients and some outpatients (total of 86 patients) and revealed that they were all HIV negative. The probability of 5-year survival (138 patients assessed) was greater in the MDR-TB group treated with alternative drugs, including the patients of the failure group. Conclusion: The MDR-TB prevalence rate found in this study is intermediate in comparison with those reported in Brazil and the other parts of the world. Preventive approaches, early diagnosis and the development of effective, safe and relatively inexpensive new drugs should be stimulated.


Jornal Brasileiro De Pneumologia | 2004

Ocorrência de tuberculose doença entre contatos de tuberculose sensível e multirresistente

Elizabeth Clara Barroso; Rosa Maria Salani Mota; Valéria Goes Ferreira Pinheiro; Jorge Luis Nobre Rodrigues

INTRODUCAO: Desde os primeiros anos da quimioterapia anti-tuberculose, existe polemica a respeito da transmissibilidade, infectividade, virulencia e patogenicidade de bacilos sensiveis e resistentes a quimioterapia. OBJETIVO: Determinar a ocorrencia de casos de tuberculose doenca entre contatos intra-domiciliares de tuberculose multirresistente e tuberculose sensivel. METODO: Foi realizado um estudo caso-controle, sendo considerado tuberculose multirresistente o caso de portador de bacilo resistente a pelo menos rifampicina e isoniazida, e tuberculose sensivel o caso que tivesse feito o primeiro tratamento num periodo semelhante ao primeiro tratamento do caso de tuberculose multirresistente, estando o paciente curado no momento da entrevista. Contato foi definido como o residente no domicilio do caso indice. Os casos foram selecionados a partir dos resultados dos testes de sensibilidade obtidos pelo metodo das proporcoes no Laboratorio Central do Estado do Ceara, e os controles constituidos por pacientes baciliferos registrados no Programa de Controle da Tuberculose, entre 1.990 e 1.999. RESULTADOS: Foram avaliados 126 portadores de tuberculose multirresistente e 176 de tuberculose sensivel. O numero de contatos foi de 557 no grupo dos casos, 752 no grupo controle e a media de contatos por caso indice foi de 4,42 e 4,27 respectivamente. Entre os casos, 4,49% dos contatos (25/557) fizeram tratamento para tuberculose apos os casos indices. Esse percentual foi de 5,45% (41/752) entre os controles (p = 0,4468). Ocorreu micro-epidemia de tuberculose multirresistente confirmada por teste de sensibilidade em oito familias. CONCLUSAO: Os resultados deste estudo sugerem que a ocorrencia de tratamentos de tuberculose gerados entre contatos intra-domiciliares de tuberculose sensivel e tuberculose multirresistente e semelhante.


Jornal Brasileiro De Pneumologia | 2008

Castleman's disease accompanied by pleural effusion

Valéria Goes Ferreira Pinheiro; Geórgea Hermógenes Fernandes; Lia Cavalcante Cezar; Newton de Albuquerque Alves; Dalgimar Beserra de Menezes

Castlemans disease is a rare disorder of the lymphoid tissue. We report the case of a female patient with bilateral otosclerosis, no respiratory symptoms, and pleural effusion discovered as an incidental finding on a chest X-ray. Computed tomography of the chest revealed a mediastinal mass. The biopsy findings demonstrated that it was a plasmacytic variant of Castlemans disease. The patient underwent mediastinal mass resection. This resulted in near-total resolution of the effusion, which remained as a small loculation within the left pleural space.


Jornal Brasileiro De Pneumologia | 2011

Diagnóstico e tratamento da tuberculose latente em pacientes com doenças inflamatórias crônicas e uso de imunobiológicos inibidores do TNF-α

Diana Maria de Almeida Lopes; Valéria Goes Ferreira Pinheiro; Helena Serra Azul Monteiro; José Ajax Nogueira Queiroz; Lucivaldo dos Santos Madeira; Mônica Maria de Almeida Lopes

OBJECTIVE To determine the clinical and epidemiological profile of patients who are candidates for TNF-α inhibitor use and are classified as having latent tuberculosis (LTB), as well as to evaluate the outcomes of prophylactic treatment with isoniazid. METHODS A prospective descriptive analysis followed by an analytical, observational, cross-sectional study of the outcomes of prophylactic treatment in a group of 45 candidates for TNF-α inhibitor use. We evaluated the patients through anamnesis, clinical examination, chest X-ray, and tuberculin skin test (TST) using the Mantoux method. RESULTS The mean age was 45 years, and 56.0% of the patients were female. Chronic rheumatic diseases, chronic dermatological diseases, and Crohns disease were present in 46.7%, 40.0%, and 13.3% of the patients, respectively. The mean TST induration was 14.6 mm (range: 5-30 mm). The majority (n = 30) of the 45 patients (66.7%) had an induration > 10 mm. In the 16 patients with BCG vaccination scars, the mean induration was 15.7 mm, and 14 of those patients had an induration > 10 mm. Chest X-ray results were considered normal, with minimal alterations, in 64.4% and 35.6% of the patients, respectively. The treatment with isoniazid was abandoned by 1 patient (2.2%) and completed by 41 (91.2%), whereas it was interrupted because of drug-induced hepatitis in 2 (4.4%), and 1 patient (2.2%) was transferred to another hospital. Of those who completed the treatment, 5 experienced mild side effects. CONCLUSIONS Determining the profile of candidates for TNF-α inhibitor use is important for the management of LTB treatment and for the establishment of clinical protocols for the use and monitoring of the use of these medications.


Brazilian Journal of Infectious Diseases | 2009

Intestinal barrier function and serum concentrations of rifampin, isoniazid and pyrazinamide in patients with pulmonary tuberculosis

Mônica Cardoso Façanha; Argina M.B. Gondim; Valéria Goes Ferreira Pinheiro; Elizabeth Clara Barroso; Charles A. Peloquin; Richard L. Guerrant; Aldo A. M. Lima

Intestinal barrier function and serum concentrations of rifampin, isoniazid and pyrazinamide were studied in healthy controls and patients with active pulmonary tuberculosis. A case-control study of 29 controls and 30 cases attending at the Health Center, July, 2004 to December, 2005 was conducted. The body mass index was significantly reduced in cases compared to controls (p < 0.001). The intestinal paracellular transport of lactulose was significantly (p = 0.019) reduced in cases compared to controls. The transcellular transport of mannitol and the lactulose:mannitol ratio were not significantly (p = 0.0698) reduced in cases compared to controls. Low serum concentrations of rifampin, isoniazid and pyrazinamide were observed in 81% (48/59), 92% (54/59) and 28% (12/59), respectively, in all individuals. The results demonstrated a marked decrease on intestinal paracellular transport in patients with active pulmonary tuberculosis and reduced serum concentrations of rifampin and isoniazid in both groups.


Jornal Brasileiro De Pneumologia | 2008

Gravidez em paciente com microlitíase alveolar pulmonar grave

José Osmar Bezerra de Souza Filho; Cristiane Maria Cavalcante Silveira; Aline Barreto da Cunha; Valéria Goes Ferreira Pinheiro; Francisco Edson de Lucena Feitosa; Marcelo Alcântara Holanda

Pulmonary alveolar microlithiasis (PAM) is a rare disease that affects both lungs. It is characterized by the presence of small calculi (calcium phosphate) within the alveolar spaces. We report the case of a 26-year-old female whose diagnosis was based on characteristic findings on chest X-rays and high-resolution computed tomography scans. The patient, 28 weeks pregnant, was rehospitalized 10 months after the diagnosis, presenting hypoxemic acute respiratory failure and severe restrictive ventilatory defect on spirometry. After 32 completed weeks of gestation (228 days), she was submitted to cesarean section, and the outcome was successful for mother and newborn. PAM has a variable clinical course. It is suggestive of an autosomal recessive inheritance pattern and has been associated with positive family history. The etiology of PAM is unclear, and many authors speculate that there is a local enzymatic defect responsible for the intra-alveolar accumulation of calcium. Reports of patients with PAM who become pregnant are exceptional, and this is the first case described in Brazil. The course of this disease is usually slow and progressive, and patients typically die of cardiorespiratory failure. The present case illustrates the need to offer female patients, especially those with advanced disease, genetic counseling and orientation regarding the risks of pregnancy. Currently, the only effective therapy is lung transplantation.


Revista Brasileira em Promoção da Saúde | 2012

Tuberculose em ambiente hospitalar: perfil clínico em hospital terciário do ceará e grau de conhecimento dos profissionais de saúde acerca das medidas de controle -doi:10.5020/18061230.2010.p260

Roberto da Justa Pires Neto; Carolina Oliveira Costa; João Bosco Breckenfeld Bastos Filho; Juliana de Melo Matos Lins; Roney Gonçalves Fechine Feitosa; Terezinha do Menino Jesus Silva Leitão; Mônica Cardoso Façanha; Valéria Goes Ferreira Pinheiro

(TB) and to assess the knowledge of health personnel on fundamental concepts about TB and control measures for pulmonary tuberculosis in a hospital environment. Methods: The study was conducted in a tertiary hospital in Fortaleza-CE and involved patients admitted with TB and health professionals responsible for assistance. A first phase was characterized by a retrospective study of medical records of patients admitted with suspected TB. In a second stage, a cross-sectional study with application of a structured questionnaire assessed the knowledge of health personnel on TB control measures in a hospital environment. Results: Sixty-seven patients admitted with suspected TB had their medical records assessed. Among the confirmed cases, the most frequent clinical form was pulmonary (81.3%). Out of 55 patients admitted with suspected pulmonary tuberculosis, only 29 (52.7%) were admitted in a respiratory isolation bed. Twenty-six patients with suspected pulmonary tuberculosis on admission stayed a total of 148 days out of a respiratory isolation bed (average 4.1 days / patient). The knowledge of 159 health professionals about TB was assessed. Regarding the transmission of TB, 107 (67.2%) were unaware of airborne transmission and 109 (68.5%) ignored the clinical forms that require respiratory isolation. Conclusions: Pulmonary tuberculosis is the most frequent clinical form among inpatients in a tertiary hospital in Fortaleza- CE. Considerable fraction of health personnel doesn’t know key concepts related to tuberculosis and essential for the proper and safe care.


American Journal of Tropical Medicine and Hygiene | 2009

Serum Concentrations of Rifampin, Isoniazid, and Intestinal Absorption, Permeability in Patients with Multidrug Resistant Tuberculosis

Elizabeth Clara Barroso; Valéria Goes Ferreira Pinheiro; Mônica Cardoso Façanha; Maria Ruth Carvalho; Maria E. Moura; Charles A. Peloquin; Richard L. Guerrant; Aldo A. M. Lima

Collaboration


Dive into the Valéria Goes Ferreira Pinheiro's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

José Alexandre Freitas Barrigossi

Empresa Brasileira de Pesquisa Agropecuária

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge